Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • An Ode to Show Directors! Lifestyle
  • Ashoka Founder Pranav Gupta – Budget 2023 will make India a knowledge-based economy Business
  • DS Jindal Group Enters Cement Market with Flujo Brand, Focusing on East India Business
  • Alankit Ltd. Shortlisted as National Business Correspondent for Punjab National Bank (PNB) Business
  • Amitabh Bachchan announces the debut of his NFT collection with BeyondLife.club Business
  • Shaping the Future of Healthcare: IIT Delhi Introduces Online PG Diploma in Healthcare Product Development and Management Education
  • Solve the Mysteries of Astro Numerology, Meet Grekky, Your Trusted Guide Lifestyle
  • Space N Living launches in Ahmedabad with end-to-end interior design and execution solutions Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • MINI TIRUPUR IN SURAT, Get tirupur based garments at tirupur prices in surat Business
  • KOTRA, Invest India Join Hands to Introduce Indian ODOP Brands to Korean Community Business
  • Namo eWaste Management IPO To Open On 4th September, Sets Price Band At Rs 80 to Rs 85 Per Share Business
  • BroBazaar Partners With NAREDCO for Upcoming NAREDCO Haryana Real Estate Summit 2022 Business
  • Gultesham: The Actor with a Growing Resume of Accomplishments Business
  • Refrain from Overpackaging When it Comes to Your Products Business

Recent Posts

  • How Sarvam AI Is Powering India’s Push for AI Self-Reliance
  • IMS Ghaziabad (University Courses Campus) to Host International Faculty Development Programme with UNESCO-ICHEI Expert
  • Three athletes of Odisha AM/NS India Gymnastics High-Performance Centre to represent India in the Commonwealth Games 2026
  • Buy Crypto Press Release dot com Launches as a New Initiative by BHMarketer.ai to Power Media Visibility for Blockchain and Web3 Projects
  • Foam Home Marks 50 Years with the Launch of Circadia, a Premium Sleep Collection

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Chhaviraj Pandey’s Incredible Journey, A Source of Inspiration National
  • Founder of Trading Villa, Ranvijay Chaudhary sheds light on key aspects of the stock market Business
  • Dr. Kannan Vishwanatth to set up a World-Class Herbal Research Centre in Riga, Latvia Press Release
  • RatnaVeer Precision Engineering Limited Announces Qualified Institutional Placement (QIP) – Deal Launch Business
  • Design That Thinks, Builds, and Leads the Future Education
  • Vertu official India- an online smartphone store with amazing collection Business
  • Tirupati Packers and Movers Expands Nationwide Relocation Services Across India Business
  • PKH Ventures Ltd launches Public Issue of up to Rs. 379.35 crores Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme